Tapewire

NYSE · USD

JNJ

JOHNSON & JOHNSON

Export transactions ↓
Tapewire entity
2722
SEC CIK
0000200406
Parsed reports
1,771

Last 12 months

Inside the activity.

1 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202602
Feb 2026015
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202601
Aug 202607
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 17, 2022 Filed Mar 21, 2022 20:38 UTC
Mongon ThibautExec VP, WW Chair, Consumer
Exercise / conversionCommon Stock 10,800 $101.87 $1,100,196.00
Disclosure

SEC source: 0001225208-22-004924 · doc4.xml · nonDerivative · entry 2

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,688.2661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 17, 2022 Filed Mar 21, 2022 20:38 UTC
Mongon ThibautExec VP, WW Chair, Consumer
Exercise / conversionCommon Stock 19,985 $100.06 $1,999,699.10
Disclosure

SEC source: 0001225208-22-004924 · doc4.xml · nonDerivative · entry 1

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,888.2661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 17, 2022 Filed Mar 21, 2022 20:38 UTC
Mongon ThibautExec VP, WW Chair, Consumer
SaleCommon Stock 6,566 $176.24 $1,157,178.71
Disclosure

SEC source: 0001225208-22-004925 · doc4.xml · nonDerivative · entry 9

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,133.2661

Read SEC document
March 17, 2022 Filed Mar 21, 2022 20:38 UTC
Mongon ThibautExec VP, WW Chair, Consumer
SaleCommon Stock 3,770 $176.16 $664,123.20
Disclosure

SEC source: 0001225208-22-004925 · doc4.xml · nonDerivative · entry 8

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,699.2661

Read SEC document
March 17, 2022 Filed Mar 21, 2022 20:38 UTC
Mongon ThibautExec VP, WW Chair, Consumer
SaleCommon Stock 2,944 $176.28 $518,959.49
Disclosure

SEC source: 0001225208-22-004925 · doc4.xml · nonDerivative · entry 7

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,469.2661

Read SEC document
March 17, 2022 Filed Mar 21, 2022 20:38 UTC
Mongon ThibautExec VP, WW Chair, Consumer
SaleCommon Stock 1,976 $176.28 $348,323.35
Disclosure

SEC source: 0001225208-22-004925 · doc4.xml · nonDerivative · entry 6

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,413.2661

Read SEC document
March 17, 2022 Filed Mar 21, 2022 20:38 UTC
Mongon ThibautExec VP, WW Chair, Consumer
SaleCommon Stock 1,856 $176.28 $327,170.11
Disclosure

SEC source: 0001225208-22-004925 · doc4.xml · nonDerivative · entry 5

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,389.2661

Read SEC document
March 17, 2022 Filed Mar 21, 2022 20:38 UTC
Mongon ThibautExec VP, WW Chair, Consumer
SaleCommon Stock 1,757 $176.28 $309,718.69
Disclosure

SEC source: 0001225208-22-004925 · doc4.xml · nonDerivative · entry 4

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,245.2661

Read SEC document
March 17, 2022 Filed Mar 21, 2022 20:38 UTC
Mongon ThibautExec VP, WW Chair, Consumer
SaleCommon Stock 1,735 $176.28 $305,840.60
Disclosure

SEC source: 0001225208-22-004925 · doc4.xml · nonDerivative · entry 3

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,002.2661

Read SEC document
March 17, 2022 Filed Mar 21, 2022 20:38 UTC
Mongon ThibautExec VP, WW Chair, Consumer
SaleCommon Stock 1,657 $176.28 $292,090.99
Disclosure

SEC source: 0001225208-22-004925 · doc4.xml · nonDerivative · entry 2

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,737.2661

Read SEC document
March 17, 2022 Filed Mar 21, 2022 20:38 UTC
Mongon ThibautExec VP, WW Chair, Consumer
SaleCommon Stock 1,420 $176.28 $250,313.34
Disclosure

SEC source: 0001225208-22-004925 · doc4.xml · nonDerivative · entry 1

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,394.2661

Read SEC document
March 15, 2022 Filed Mar 17, 2022 20:30 UTC
Decker Robert JController, CAO
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative 5,000 $0.00 Strike: $72.54 $0.00
Disclosure

SEC source: 0001225208-22-004862 · doc4.xml · derivative · entry 7

Decker Robert J · CIK 0001798703 · Controller, CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,462

Underlying: Common Stock · 5,000 shares

Expires 2023-01-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2022 Filed Mar 17, 2022 20:30 UTC
Decker Robert JController, CAO
SaleCommon Stock 2,750 $175.51 $482,641.50
Disclosure

SEC source: 0001225208-22-004862 · doc4.xml · nonDerivative · entry 4

Decker Robert J · CIK 0001798703 · Controller, CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,473

Read SEC document
March 15, 2022 Filed Mar 17, 2022 20:30 UTC
Decker Robert JController, CAO
SaleCommon Stock 2,000 $175.51 $351,012.00
Disclosure

SEC source: 0001225208-22-004862 · doc4.xml · nonDerivative · entry 3

Decker Robert J · CIK 0001798703 · Controller, CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,223

Read SEC document
March 15, 2022 Filed Mar 17, 2022 20:30 UTC
Decker Robert JController, CAO
SaleCommon Stock 250 $175.51 $43,876.50
Disclosure

SEC source: 0001225208-22-004862 · doc4.xml · nonDerivative · entry 2

Decker Robert J · CIK 0001798703 · Controller, CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,223

Read SEC document
March 15, 2022 Filed Mar 17, 2022 20:30 UTC
Decker Robert JController, CAO
Exercise / conversionCommon Stock 5,000 $72.54 $362,700.00
Disclosure

SEC source: 0001225208-22-004862 · doc4.xml · nonDerivative · entry 1

Decker Robert J · CIK 0001798703 · Controller, CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 08, 2022 Filed Mar 9, 2022 22:50 UTC GrantDeferred Share Units · Derivative 245.836 $170.26 $41,856.04
Disclosure

SEC source: 0001225208-22-004416 · doc4.xml · derivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,534.589

Underlying: Common Stock · 245.836 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
March 08, 2022 Filed Mar 9, 2022 22:50 UTC GrantDeferred Share Units · Derivative 349.982 $170.26 $59,587.94
Disclosure

SEC source: 0001225208-22-004418 · doc4.xml · derivative · entry 1

Washington A. Eugene · CIK 0001561989 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,083.9113

Underlying: Common Stock · 349.982 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
March 08, 2022 Filed Mar 9, 2022 22:50 UTC GrantDeferred Share Units · Derivative 215.95 $170.26 $36,767.65
Disclosure

SEC source: 0001225208-22-004417 · doc4.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,421.317

Underlying: Common Stock · 215.95 shares

Expires not disclosed

F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Gorsky AlexDirector
Exercise / conversionPerformance Share Units · Derivative 60,965 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002371 · doc4.xml · derivative · entry 7

Gorsky Alex · CIK 0001453149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,809

Underlying: Common Stock · 60,965 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

F7 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Gorsky AlexDirector
Tax withholdingCommon Stock 26,472 $165.89 $4,391,440.08
Disclosure

SEC source: 0001225208-22-002371 · doc4.xml · nonDerivative · entry 2

Gorsky Alex · CIK 0001453149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 585,447.15

F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Gorsky AlexDirector
Exercise / conversionCommon Stock 60,965 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002371 · doc4.xml · nonDerivative · entry 1

Gorsky Alex · CIK 0001453149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 611,919.15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Ullmann Michael HExec VP, General Counsel
Exercise / conversionPerformance Share Units · Derivative 13,186 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002367 · doc4.xml · derivative · entry 7

Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,257

Underlying: Common Stock · 13,186 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

F7 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Ullmann Michael HExec VP, General Counsel
Tax withholdingCommon Stock 6,209 $165.89 $1,030,011.01
Disclosure

SEC source: 0001225208-22-002367 · doc4.xml · nonDerivative · entry 2

Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,834.882

F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Ullmann Michael HExec VP, General Counsel
Exercise / conversionCommon Stock 13,186 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002367 · doc4.xml · nonDerivative · entry 1

Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,043.882

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Fasolo PeterExec VP, Chief HR Officer
Exercise / conversionPerformance Share Units · Derivative 11,154 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002368 · doc4.xml · derivative · entry 5

Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,063

Underlying: Common Stock · 11,154 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

F5 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Broadhurst VanessaEVP, Global Corp Aff.
Exercise / conversionPerformance Share Units · Derivative 2,557 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002369 · doc4.xml · derivative · entry 5

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Aff.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 244

Underlying: Common Stock · 2,557 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

F5 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Broadhurst VanessaEVP, Global Corp Aff.
Tax withholdingCommon Stock 925 $165.89 $153,448.25
Disclosure

SEC source: 0001225208-22-002369 · doc4.xml · nonDerivative · entry 2

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Aff.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,667

F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Broadhurst VanessaEVP, Global Corp Aff.
Exercise / conversionCommon Stock 2,557 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002369 · doc4.xml · nonDerivative · entry 1

Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Aff.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,592

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Duato JoaquinDirector · CEO
Tax withholdingCommon Stock 12,902 $165.89 $2,140,312.78
Disclosure

SEC source: 0001225208-22-002370 · doc4.xml · nonDerivative · entry 2

Duato Joaquin · CIK 0001673401 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 245,977

F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Duato JoaquinDirector · CEO
Exercise / conversionCommon Stock 29,714 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002370 · doc4.xml · nonDerivative · entry 1

Duato Joaquin · CIK 0001673401 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 258,879

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Mammen MathaiEVP, Pharm, R&D
Exercise / conversionPerformance Share Units · Derivative 7,740 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002372 · doc4.xml · derivative · entry 5

Mammen Mathai · CIK 0001421050 · EVP, Pharm, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 737

Underlying: Common Stock · 7,740 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

F5 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Mammen MathaiEVP, Pharm, R&D
Tax withholdingCommon Stock 3,366 $165.89 $558,385.74
Disclosure

SEC source: 0001225208-22-002372 · doc4.xml · nonDerivative · entry 2

Mammen Mathai · CIK 0001421050 · EVP, Pharm, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,934

F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:00 UTC
Mammen MathaiEVP, Pharm, R&D
Exercise / conversionCommon Stock 7,740 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002372 · doc4.xml · nonDerivative · entry 1

Mammen Mathai · CIK 0001421050 · EVP, Pharm, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,300

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
McEvoy AshleyEVP, WW Chair, Medical Devices
Exercise / conversionPerformance Share Units · Derivative 15,806 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002373 · doc4.xml · derivative · entry 7

McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,506

Underlying: Common Stock · 15,806 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

F7 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
McEvoy AshleyEVP, WW Chair, Medical Devices
Tax withholdingCommon Stock 6,242 $165.89 $1,035,485.38
Disclosure

SEC source: 0001225208-22-002373 · doc4.xml · nonDerivative · entry 2

McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,812.9545

F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
McEvoy AshleyEVP, WW Chair, Medical Devices
Exercise / conversionCommon Stock 15,806 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002373 · doc4.xml · nonDerivative · entry 1

McEvoy Ashley · CIK 0001745936 · EVP, WW Chair, Medical Devices

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,054.9545

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Wolk Joseph JExec VP, CFO
Exercise / conversionPerformance Share Units · Derivative 17,793 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002375 · doc4.xml · derivative · entry 6

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,695

Underlying: Common Stock · 17,793 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

F6 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Wolk Joseph JExec VP, CFO
Tax withholdingCommon Stock 7,319 $165.89 $1,214,148.91
Disclosure

SEC source: 0001225208-22-002375 · doc4.xml · nonDerivative · entry 2

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,858.204

F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Wolk Joseph JExec VP, CFO
Exercise / conversionCommon Stock 17,793 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002375 · doc4.xml · nonDerivative · entry 1

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,177.204

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Wengel Kathryn EEVP, Chief GSC Officer
Exercise / conversionPerformance Share Units · Derivative 10,386 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002374 · doc4.xml · derivative · entry 7

Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 990

Underlying: Common Stock · 10,386 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

F7 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Wengel Kathryn EEVP, Chief GSC Officer
Tax withholdingCommon Stock 4,699 $165.89 $779,517.11
Disclosure

SEC source: 0001225208-22-002374 · doc4.xml · nonDerivative · entry 2

Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,310.8735

F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Wengel Kathryn EEVP, Chief GSC Officer
Exercise / conversionCommon Stock 10,386 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002374 · doc4.xml · nonDerivative · entry 1

Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,009.8735

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Mongon ThibautExec VP, WW Chair, Consumer
Exercise / conversionPerformance Share Units · Derivative 3,922 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002376 · doc4.xml · derivative · entry 5

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 374

Underlying: Common Stock · 3,922 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

F5 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Mongon ThibautExec VP, WW Chair, Consumer
Tax withholdingCommon Stock 1,843 $165.89 $305,735.27
Disclosure

SEC source: 0001225208-22-002376 · doc4.xml · nonDerivative · entry 2

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,903.2661

F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Mongon ThibautExec VP, WW Chair, Consumer
Exercise / conversionCommon Stock 3,922 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002376 · doc4.xml · nonDerivative · entry 1

Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,746.2661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
Exercise / conversionPerformance Share Units · Derivative 18,064 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002377 · doc4.xml · derivative · entry 5

Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,721

Underlying: Common Stock · 18,064 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

F5 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
Tax withholdingCommon Stock 8,841 $165.89 $1,466,633.49
Disclosure

SEC source: 0001225208-22-002377 · doc4.xml · nonDerivative · entry 2

Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,456.001

F2 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
Exercise / conversionCommon Stock 18,064 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002377 · doc4.xml · nonDerivative · entry 1

Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,297.001

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 11:01 UTC
Decker Robert JController, CAO
Exercise / conversionPerformance Share Units · Derivative 903 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-002378 · doc4.xml · derivative · entry 7

Decker Robert J · CIK 0001798703 · Controller, CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86

Underlying: Common Stock · 903 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

F7 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.